GlassScriptPhysician profile
Dipti Baral
NPI 1275966137
$10,908.75
in general payments reported to CMS, 2019-2025
33 companies · $1,009 in 2025
The $1,009 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.31 · 2020: $797 · 2021: $775 · 2022: $600 · 2023: $1,133 · 2024: $6,528 · 2025: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $3,249 · Travel and Lodging: $1,421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $3,249.21 |
| Travel and Lodging | $1,420.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,656.16 | 2023-2024 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $1,543.56 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Ethicon INC. | $422.13 | 2021 | |
| United Therapeutics Corporation | $334.60 | 2020-2025 | Tyvaso, Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $280.92 | 2020-2025 | Ofev |
| Astrazeneca Pharmaceuticals LP | $269.35 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Actelion Pharmaceuticals US, INC. | $235.58 | 2020-2025 | Uptravi |
| Takeda Pharmaceuticals U.S.A., INC. | $228.94 | 2020-2025 | Glassia |
| Grifols USA, LLC | $201.33 | 2021-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $198.24 | 2020-2024 | Acthar |
| Genzyme Corporation | $177.58 | 2020-2025 | |
| Electromed, INC. | $157.36 | 2023-2025 | Smartvest |
| Pulmonx Corporation | $135.80 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Merck Sharp & Dohme LLC | $127.98 | 2023-2025 | Keytruda, Zerbaxa, Dificid |
| Baxter Healthcare | $125.30 | 2023-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $113.31 | 2020 | |
| Novartis Pharmaceuticals Corporation | $107.42 | 2020-2022 | |
| Insmed, INC. | $97.45 | 2023-2025 | Arikayce |
| Mylan Specialty L.P. | $74.60 | 2020-2024 | Yupelri |
| Verona Pharma, INC. | $56.92 | 2025 | Ohtuvayre |
| Bayer Healthcare Pharmaceuticals INC. | $55.35 | 2020-2023 | |
| Abbvie INC. | $49.57 | 2024 | |
| La Jolla Pharmaceutical Company | $34.33 | 2020 | |
| Jazz Pharmaceuticals INC. | $33.56 | 2020-2021 | |
| Astellas Pharma US INC | $30.38 | 2024 | Cresemba |
| Portola Pharmaceuticals, LLC | $30.10 | 2019-2020 | |
| Inogen, INC. | $23.80 | 2022 | |
| Alexion Pharmaceuticals, INC. | $20.48 | 2023 | Ultomiris |
| Viatris Specialty LLC | $20.35 | 2025 | Yupelri |
| Genentech USA, INC. | $19.85 | 2023 | Esbriet, Xolair |
| Circassia INC. | $17.50 | 2019 | |
| Philips North America LLC | $14.94 | 2025 | Vest Therapy Und |
| Apria Healthcare LLC | $14.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dipti Baral listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.